IOTF vs. CDC | ||||
Non-agreement IOTF overweight/ CDC obese (n = 13) | Agreement IOTF obese/ CDC obese (n = 123) | Mean difference (95% CI) | P | |
Body fat, % | 34.5 ± 6.6 | 41.7 ± 6.7 | −7.1 (−11.0, −3.2) | <0.001 |
SBP, mm Hg | 104 ± 10.4 | 108 ± 11.6 | −3.5 (−10.2, 3.1) | 0.29 |
DBP, mm Hg | 63 ± 8.9 | 65 ± 11.6 | −2.1 (−8.7, 4.4) | 0.52 |
Fasting plasma glucose, mmol/L | 5.0 ± 0.40 | 5.2 ± 0.50 | −0.17 (−0.45, 0.12) | 0.26 |
Fasting plasma insulin, pmol/L | 142 ± 49 | 207 ± 135 | −65.3 (−102, −28.5) | 0.001 |
HOMA2-IR | 2.6 ± 0.86 | 3.5 ± 2.0 | −0.97 (−1.6, −0.36) | 0.003 |
TG, mmol/L | 1.1 ± 0.45 | 1.1 ± 0.61 | 0.003 (−0.50, 0.51) | 0.99 |
HDL-C, mmol/L | 1.2 ± 0.32 | 1.1 ± 0.28 | 0.11 (−0.13, 0.35) | 0.38 |
TG/HDL-C ratio | 0.97 ± 0.46 | 1.1 ± 0.72 | −0.14 (−0.74, 0.46) | 0.64 |
IOTF vs. WHO | ||||
Non-agreement IOTF overweight/ WHO obese (n = 19) | Agreement IOTF obese/ WHO obese (n = 123) | Mean difference (95% CI) | P | |
Body fat, % | 33.6 ± 6.5 | 41.7 ± 6.7 | −8.1 (−11.3, −4.8) | <0.001 |
SBP, mm Hg | 104 ± 9.3 | 108 ± 11.6 | −4.2 (−9.7, 1.3) | 0.13 |
DBP, mm Hg | 63 ± 10.1 | 65 ± 11.6 | −2.2 (−7.7, 3.4) | 0.44 |
Fasting plasma glucose, mmol/L | 5.1 ± 0.39 | 5.2 ± 0.50 | −0.12 (−0.36, 0.12) | 0.32 |
Fasting plasma insulin, pmol/L | 135 ± 55.3 | 207 ± 135 | −71.9 (−107, −36.6) | <0.001 |
HOMA2-IR | 2.5 ± 0.98 | 3.5 ± 2.0 | −1.1 (−1.7, −0.50) | <0.001 |
TG, mmol/L | 0.97 ± 0.40 | 1.1 ± 0.61 | −0.18 (−0.55, 0.20) | 0.36 |
HDL-C, mmol/L | 1.4 ± 0.35 | 1.1 ± 0.28 | 0.23 (0.04, 0.42) | 0.02 |
TG/HDL-C ratio | 0.77 ± 0.43 | 1.1 ± 0.72 | −0.34 (−0.78, 0.10) | 0.13 |